Volume 3 - Issue 1 - Jan/Feb 2006
Feature
Case Report
09/05/2008
Patent foramen ovale (PFO) is more prevalent in patients with cryptogenic stroke (CS) than in individuals with a stroke of known cause, suggesting that “paradoxical embolus” (i.e., the migration of a venous thrombus across the PFO to the...
Patent foramen ovale (PFO) is more prevalent in patients with cryptogenic stroke (CS) than in individuals with a stroke of known cause, suggesting that “paradoxical embolus” (i.e., the migration of a venous thrombus across the PFO to the...
Patent foramen ovale (PFO) is...
09/05/2008
Vascular Disease Management
Case Report
09/05/2008
Postoperative sexual dysfunction represents a significant, underdiagnosed consequence of this condition, yet many treatment options exist.
Postoperative sexual dysfunction represents a significant, underdiagnosed consequence of this condition, yet many treatment options exist.
Postoperative sexual dysfunction...
09/05/2008
Vascular Disease Management
Original Research
09/05/2008
Percutaneous transluminal renal angioplasty (PTRA) followed by subsequent stent implantation is an efficient treatment of atherosclerotic renal artery stenosis and has been shown to be associated with improvement in renal function, control of...
Percutaneous transluminal renal angioplasty (PTRA) followed by subsequent stent implantation is an efficient treatment of atherosclerotic renal artery stenosis and has been shown to be associated with improvement in renal function, control of...
Percutaneous transluminal renal...
09/05/2008
Vascular Disease Management
Original Research
09/05/2008
Critical limb ischemia (CLI) remains poorly characterized in the clinical literature. Therefore, information, knowledge and awareness surrounding the clinical impact of CLI remains obscure.
Critical limb ischemia (CLI) remains poorly characterized in the clinical literature. Therefore, information, knowledge and awareness surrounding the clinical impact of CLI remains obscure.
Critical limb ischemia (CLI)...
09/05/2008
Vascular Disease Management
Original Research
09/05/2008
The natural history of atherosclerotic renal artery stenosis is characterized by progression, causing hypertension and chronic renal failure (RF). Up to 21% of patients with renal stenosis reducing luminal diameter by more than 60% progress...
The natural history of atherosclerotic renal artery stenosis is characterized by progression, causing hypertension and chronic renal failure (RF). Up to 21% of patients with renal stenosis reducing luminal diameter by more than 60% progress...
The natural history of...
09/05/2008
Vascular Disease Management
Original Research
09/05/2008
In medically high-risk patients, carotid angioplasty and stenting (CAS) is increasingly being performed as an alternative to carotid endarterectomy (CEA) for the treatment of carotid artery stenosis. Hemodynamic instability following CEA has...
In medically high-risk patients, carotid angioplasty and stenting (CAS) is increasingly being performed as an alternative to carotid endarterectomy (CEA) for the treatment of carotid artery stenosis. Hemodynamic instability following CEA has...
In medically high-risk patients,...
09/05/2008
Vascular Disease Management
Insights
Commentary
09/05/2008
Vascular complications arising during or after percutaneous access of the femoral artery have decreased over the past decade, but still present a problem in some cases. The use of vascular closure devices for femoral artery access management...
Vascular complications arising during or after percutaneous access of the femoral artery have decreased over the past decade, but still present a problem in some cases. The use of vascular closure devices for femoral artery access management...
Vascular complications arising...
09/05/2008
Vascular Disease Management
Commentary
09/05/2008
Stenting of the renal artery is now the procedure of choice in treating obstructive atherosclerotic renal artery disease. Unfortunately, restenosis remains the Achilles’ tendon of this percutaneous therapy, and ranges from 15–25%.
Stenting of the renal artery is now the procedure of choice in treating obstructive atherosclerotic renal artery disease. Unfortunately, restenosis remains the Achilles’ tendon of this percutaneous therapy, and ranges from 15–25%.
Stenting of the renal artery is...
09/05/2008
Vascular Disease Management
Column
Editor's Corner
09/05/2008
Last year was eventful in the vascular and endovascular world. Regulatory approval (in the United States) of carotid stenting and thoracic aortic endografting was — clearly — among the most salient developments.
Last year was eventful in the vascular and endovascular world. Regulatory approval (in the United States) of carotid stenting and thoracic aortic endografting was — clearly — among the most salient developments.
Last year was eventful in the...
09/05/2008
Vascular Disease Management
